IL187470A - Device for quantitative analysis of metabolite profile - Google Patents

Device for quantitative analysis of metabolite profile

Info

Publication number
IL187470A
IL187470A IL187470A IL18747007A IL187470A IL 187470 A IL187470 A IL 187470A IL 187470 A IL187470 A IL 187470A IL 18747007 A IL18747007 A IL 18747007A IL 187470 A IL187470 A IL 187470A
Authority
IL
Israel
Prior art keywords
quantitative analysis
metabolite profile
metabolite
profile
quantitative
Prior art date
Application number
IL187470A
Other languages
English (en)
Hebrew (he)
Other versions
IL187470A0 (en
Original Assignee
Biocrates Life Sciences Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrates Life Sciences Ag filed Critical Biocrates Life Sciences Ag
Publication of IL187470A0 publication Critical patent/IL187470A0/en
Publication of IL187470A publication Critical patent/IL187470A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00594—Quality control, including calibration or testing of components of the analyser
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G16B50/30—Data warehousing; Computing architectures
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioethics (AREA)
  • Databases & Information Systems (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Quality & Reliability (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
IL187470A 2005-06-30 2007-11-19 Device for quantitative analysis of metabolite profile IL187470A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69498305P 2005-06-30 2005-06-30
US69498405P 2005-06-30 2005-06-30
PCT/EP2006/006328 WO2007003344A2 (en) 2005-06-30 2006-06-29 Device for quantitative analysis of a metabolite profile

Publications (2)

Publication Number Publication Date
IL187470A0 IL187470A0 (en) 2008-03-20
IL187470A true IL187470A (en) 2015-02-26

Family

ID=36783737

Family Applications (1)

Application Number Title Priority Date Filing Date
IL187470A IL187470A (en) 2005-06-30 2007-11-19 Device for quantitative analysis of metabolite profile

Country Status (16)

Country Link
US (2) US8116983B2 (cg-RX-API-DMAC7.html)
EP (2) EP1875401B1 (cg-RX-API-DMAC7.html)
JP (2) JP5155160B2 (cg-RX-API-DMAC7.html)
KR (1) KR100967573B1 (cg-RX-API-DMAC7.html)
CN (1) CN100594501C (cg-RX-API-DMAC7.html)
AU (1) AU2006265381B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0613478B8 (cg-RX-API-DMAC7.html)
CA (2) CA2608963C (cg-RX-API-DMAC7.html)
DK (2) DK1875401T3 (cg-RX-API-DMAC7.html)
ES (1) ES2452025T3 (cg-RX-API-DMAC7.html)
IL (1) IL187470A (cg-RX-API-DMAC7.html)
IN (1) IN2014DN02241A (cg-RX-API-DMAC7.html)
NO (1) NO339319B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ563431A (cg-RX-API-DMAC7.html)
RU (1) RU2391672C2 (cg-RX-API-DMAC7.html)
WO (2) WO2007003344A2 (cg-RX-API-DMAC7.html)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
US8969089B2 (en) 2004-10-12 2015-03-03 Quest Diagnostics Investments, Inc. Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
ES2452025T3 (es) * 2005-06-30 2014-03-31 Biocrates Life Sciences Ag Aparato de análisis de un perfil de metabolitos
CN101484808B (zh) * 2006-05-05 2015-11-25 珀金埃尔默·拉斯公司 用质谱法定量分析源自表面的样品
EP1923806A1 (en) * 2006-11-14 2008-05-21 Metanomics GmbH Fast metabolomic analysis and system therefor
US7999084B2 (en) * 2007-05-16 2011-08-16 Agilent Technologies, Inc. Devices and methods for reducing matrix effects
US20100233746A1 (en) * 2007-05-31 2010-09-16 Denise Sonntag Inflammation and Oxidative Stress Level Assay
JP2010527624A (ja) * 2007-05-31 2010-08-19 バイオクレイツ ライフ サイエンス エージー 酸化ストレスレベルを測定するためのバイオマーカーおよび方法
EP3543691A1 (en) * 2007-06-29 2019-09-25 Quest Diagnostics Investments Incorporated Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry
US12367163B2 (en) 2007-06-29 2025-07-22 Quest Diagnostics Investments Llc Analysis of amino acids in body fluid by liquid chromatography—mass spectrometry
AU2008280806B2 (en) * 2007-07-26 2014-12-11 Phenomenome Discoveries Inc. Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
DE102007043614B3 (de) * 2007-09-13 2008-11-20 Biocrates Life Sciences Gmbh Halterung für ein Trägermittel zum Einsetzen in eine zylinderförmige Öffnung
EP2208074A4 (en) * 2007-10-01 2010-12-22 Dh Technologies Dev Pte Ltd ANALYSIS OF CONJUGATED METABOLIC PRODUCTS OF THE ALCOHOL CONSUMPTION
EP2215460A4 (en) * 2007-11-26 2010-12-29 Waters Technologies Corp INTERNAL STANDARDS AND METHODS FOR USE IN MEASURING QUANTITATIVELY ANALYTES IN A SAMPLE
EP2297771A2 (en) * 2008-06-13 2011-03-23 Smiths Detection-Montreal Inc. Analytical instrument
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
EP2730662A1 (en) 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
EP2192196A1 (en) 2008-11-27 2010-06-02 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Prediction of lipid-metabotype-related physiological susceptibilities
US20120058009A1 (en) 2009-03-05 2012-03-08 Hitachi High-Technologies Corporation Analyzer
US9500572B2 (en) 2009-04-30 2016-11-22 Purdue Research Foundation Sample dispenser including an internal standard and methods of use thereof
CA2759987C (en) * 2009-04-30 2018-10-02 Purdue Research Foundation Ion generation using wetted porous material
EP2249161B1 (en) * 2009-05-05 2020-05-13 InfanDx AG Method of diagnosing asphyxia
BRPI0924639B1 (pt) 2009-06-02 2021-12-07 Biocrates Life Sciences Ag Novos biomarcadores para avaliação de doenças renais
CA2782284A1 (en) 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
WO2011088226A2 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings Detection of gastrointestinal disorders
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
HUE055674T2 (hu) * 2010-10-29 2021-12-28 Thermo Fisher Scientific Oy Rendszerelrendezés automatizált mintaelõkészítõ és -elemzõ rendszerhez
SG190048A1 (en) * 2010-10-29 2013-06-28 Atonarp Inc Analysis apparatus
EP2492690A1 (en) * 2011-02-22 2012-08-29 BIOCRATES Life Sciences AG Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants
EP2587264A1 (en) 2011-10-25 2013-05-01 InfanDx AG Method and use of metabolites for the diagnosis and differentiation of neonatal encephalopathy
EP3557605B1 (en) 2011-11-23 2021-07-14 Quest Diagnostics Investments Incorporated Kisspeptin-54 detection by tandem mass spectrometry
JP6198408B2 (ja) * 2012-04-02 2017-09-20 株式会社日立ハイテクノロジーズ サンプル液に含まれる揮発性物質の分析方法
US8870028B2 (en) 2012-05-25 2014-10-28 Restek Corporation Dispensing device
EP2883058B1 (en) * 2012-08-13 2018-01-03 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Biomarkers for type 2 diabetes
EP2917738A1 (de) 2012-11-12 2015-09-16 BIOCRATES Life Sciences AG Verwendung von qualitätsindikatoren zum nachweis von auftauprozessen in gefrorenen gewebeproben
WO2014110196A1 (en) * 2013-01-10 2014-07-17 Restek Corporation Dispensing device and method
US9733228B2 (en) 2013-01-31 2017-08-15 Purdue Research Foundation Methods of analyzing crude oil
EP3742472A1 (en) 2013-01-31 2020-11-25 Purdue Research Foundation Methods for analyzing an extracted sample
US9620344B2 (en) 2013-06-25 2017-04-11 Purdue Research Foundation Mass spectrometry analysis of microorganisms in samples
CN103558354B (zh) * 2013-11-15 2015-07-15 南京大学 一种基于生物组学整合技术的水体毒性分析方法
JP2017101924A (ja) * 2014-03-31 2017-06-08 積水メディカル株式会社 内部標準物質試薬
CN104200087B (zh) * 2014-06-05 2018-10-02 清华大学 用于机器学习的参数寻优及特征调优的方法及系统
US9786478B2 (en) 2014-12-05 2017-10-10 Purdue Research Foundation Zero voltage mass spectrometry probes and systems
WO2016127177A1 (en) 2015-02-06 2016-08-11 Purdue Reserach Foundation Probes, systems, cartridges, and methods of use thereof
EP3171173A1 (en) 2015-11-19 2017-05-24 Medizinische Universität Innsbruck Method of diagnosis of a thoracic aortic aneurysm
US10001501B2 (en) 2015-12-31 2018-06-19 Universal Diagnostics, S. L. Systems and methods for automated, customizable sample preparation for detection of metabolites and lipids
DE102017112612A1 (de) * 2016-06-10 2017-12-14 Hitachi High-Tech Science Corporation Flüssigkeitschromatograph und Verfahren zum Korrigieren von Schwankungen eines Detektorausgabewerts des Flüssigkeitschromatographen
US10607723B2 (en) 2016-07-05 2020-03-31 University Of Kentucky Research Foundation Method and system for identification of metabolites using mass spectra
WO2018085835A1 (en) 2016-11-07 2018-05-11 Battelle Memorial Institute Nanoscale biochemical sample preparation and analysis
US11719702B2 (en) * 2016-11-07 2023-08-08 Battelle Memorial Institute Methods and systems of proteome analysis and imaging
EP3351938A1 (en) 2017-01-18 2018-07-25 BIOCRATES Life Sciences AG New biomarkers for assessing ovarian cancer
EP3376230A1 (en) 2017-03-13 2018-09-19 Biocross, S.L. Identification of signatures for neurodegeneration diseases diagnoses
WO2018174876A1 (en) * 2017-03-22 2018-09-27 Mprobe Inc. Methods and compositions for providing a preeclampsia assessment with metabolites
CN107727850B (zh) * 2017-10-10 2021-08-27 常州博闻迪医药股份有限公司 一种侧向流层析检测反应启动控制方法
JP6991436B2 (ja) * 2017-05-17 2022-01-12 ラジオメーター・メディカル・アー・ペー・エス 流体中の検体を検出するための多孔質光ファイバ
CN107561150A (zh) * 2017-07-03 2018-01-09 宁波华仪宁创智能科技有限公司 吸毒的检测方法
CN107798981A (zh) * 2017-10-31 2018-03-13 楚雄医药高等专科学校 一种永久性教学用微囊标本片及其制作方法
CN109030673A (zh) * 2018-07-04 2018-12-18 易达精准（杭州）科技有限公司 干血片中免疫抑制剂的检测方法以及检测试剂盒
CN109298115B (zh) * 2018-10-19 2020-07-28 深圳市绘云生物科技有限公司 生物样品中多种代谢物定量检测方法及代谢芯片
WO2020099683A1 (en) 2018-11-16 2020-05-22 Biocrates Life Sciences Ag Metabolites for use in ovarian cancer detection and diagnosis
FR3091351B1 (fr) 2018-12-27 2021-05-21 Univ Rouen Centre Hospitalier Biomarqueur de la maladie de fabry
KR102035162B1 (ko) * 2019-03-12 2019-11-08 한국과학기술원 질병 표적 대사 효소에 특이적인 인체 대사 물질을 이용하여 질병에 대한 약물 후보를 예측하는 방법
AU2020279748A1 (en) 2019-05-20 2021-12-23 Battelle Energy Alliance, Llc Spark plasma sintering methods for fabricating dense graphite
GB201916046D0 (en) * 2019-11-04 2019-12-18 Amazentis Sa Diagnostic method
CN111579665B (zh) * 2020-05-20 2021-11-05 苏州帕诺米克生物医药科技有限公司 一种基于uplc/hrms的代谢组学相对定量分析方法
US20230204544A1 (en) * 2020-05-21 2023-06-29 Mayo Foundation For Medical Education And Research Calibration methods for mass spectrometry measurements
CN111704654B (zh) * 2020-06-18 2021-12-03 上海交通大学医学院附属仁济医院 肽类化合物及其制备方法与应用
WO2023069732A1 (en) * 2021-10-21 2023-04-27 Pinpoint Testing, Llc Ready-to-constitute analytical platforms for chemical analyses and quantification of analytes in biological samples
US11754536B2 (en) 2021-11-01 2023-09-12 Matterworks Inc Methods and compositions for analyte quantification
US12100484B2 (en) 2021-11-01 2024-09-24 Matterworks Inc Methods and compositions for analyte quantification
JP7206365B1 (ja) * 2021-12-22 2023-01-17 浜松ホトニクス株式会社 試料支持体
KR102547430B1 (ko) * 2022-11-16 2023-06-23 (주)애터미오롯 노니 함유 조성물의 정성 분석 방법
WO2024123681A2 (en) * 2022-12-05 2024-06-13 Washington University Improved method for scalable untargeted metabolomic workflow
GB2636339A (en) 2023-08-30 2025-06-18 Cambridge Entpr Ltd Biomarkers for bipolar disorder
CN117538530B (zh) * 2023-11-07 2024-07-19 中国医学科学院肿瘤医院 一种检测转移性乳腺癌的生物标志组合物和试剂盒及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017155C1 (ru) * 1993-05-05 1994-07-30 Геннадий Степанович Власов Диагностическое устройство для иммунохимического анализа
US5756362A (en) 1993-10-12 1998-05-26 Cornell Research Foundation, Inc. Liposome-enhanced immunoaggregation assay and test device
US6358752B1 (en) 1996-09-27 2002-03-19 Cornell Research Foundation, Inc. Liposome-enhanced test device and method
GB9718129D0 (en) * 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6455321B1 (en) * 1999-01-30 2002-09-24 Neo Gen Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US6258605B1 (en) * 1999-03-26 2001-07-10 Neo Gen Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry
US20020009394A1 (en) 1999-04-02 2002-01-24 Hubert Koster Automated process line
EP1113269B1 (en) * 1999-12-29 2006-10-18 PerkinElmer Life Sciences, Inc. Test tray, kit and methods for screening body fluids of newborns by tandem mass spectrometry
WO2001078652A2 (en) * 2000-04-14 2001-10-25 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
JP2004518944A (ja) * 2000-07-18 2004-06-24 インヴィトロジェン コーポレーション ゲル材料を細分および濾過して分子を抽出するための装置および方法
US6627444B1 (en) * 2000-08-07 2003-09-30 Smiths Detection - Toronto Ltd. Method and solid phase calibration sample for calibration of analytical instructions
US20020155587A1 (en) * 2001-04-20 2002-10-24 Sequenom, Inc. System and method for testing a biological sample
DE60225145D1 (de) 2001-07-06 2008-04-03 Lipomics Technologies Inc Erzeugen, betrachten, interpretieren und verwenden einer quantitativen datenbank von metaboliten
WO2003016861A2 (en) 2001-08-14 2003-02-27 President And Fellows Of Harvard College Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry
US6929944B2 (en) * 2001-08-31 2005-08-16 Beckman Coulter, Inc. Analysis using a distributed sample
US6939716B2 (en) 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
EP1446667A2 (en) * 2001-11-13 2004-08-18 Caprion Pharmaceuticals, Inc. Mass intensity profiling system and uses thereof
EP1481356A1 (en) * 2001-11-21 2004-12-01 Paradigm Genetics Inc. Methods and systems for analyzing complex biological systems
GB0128498D0 (en) 2001-11-28 2002-01-23 Inst Of Child Health International standards for sphingolipids
US20050092910A1 (en) * 2001-12-08 2005-05-05 Scott Geromanos Method of mass spectrometry
AUPS177202A0 (en) * 2002-04-16 2002-05-23 Diakyne Pty Ltd Multi-element screening of trace elements
WO2004038602A1 (en) 2002-10-24 2004-05-06 Warner-Lambert Company, Llc Integrated spectral data processing, data mining, and modeling system for use in diverse screening and biomarker discovery applications
WO2004038381A2 (en) 2002-10-25 2004-05-06 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20040119010A1 (en) * 2002-11-01 2004-06-24 The Regents Of The University Of Colorado Quantitative analysis of protein isoforms using matrix-assisted laser desorption/ionization time of flight mass spectrometry
US20040121305A1 (en) 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
US6909981B2 (en) * 2003-01-27 2005-06-21 Ciphergen Biosystems, Inc. Data management system and method for processing signals from sample spots
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
AU2004276760B2 (en) * 2003-09-22 2010-03-04 Becton, Dickinson And Company Quantification of analytes using internal standards
KR20050050714A (ko) * 2003-11-26 2005-06-01 매그나칩 반도체 유한회사 반도체소자의 트랜지스터 제조방법
US7745226B2 (en) * 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
ES2452025T3 (es) * 2005-06-30 2014-03-31 Biocrates Life Sciences Ag Aparato de análisis de un perfil de metabolitos

Also Published As

Publication number Publication date
CA2608965A1 (en) 2007-01-11
KR100967573B1 (ko) 2010-07-05
US8116983B2 (en) 2012-02-14
CA2608963A1 (en) 2007-01-11
KR20080025092A (ko) 2008-03-19
IL187470A0 (en) 2008-03-20
IN2014DN02241A (cg-RX-API-DMAC7.html) 2015-07-10
BRPI0613478A2 (pt) 2012-01-17
CA2608965C (en) 2014-08-19
JP5155160B2 (ja) 2013-02-27
EP1875401A2 (en) 2008-01-09
WO2007003344A2 (en) 2007-01-11
DK1875401T3 (da) 2014-04-07
BRPI0613478B8 (pt) 2021-07-27
BRPI0613478B1 (pt) 2019-07-09
ES2452025T3 (es) 2014-03-31
EP1875401B1 (en) 2014-03-05
RU2391672C2 (ru) 2010-06-10
JP4829297B2 (ja) 2011-12-07
JP2008547031A (ja) 2008-12-25
CN101208697A (zh) 2008-06-25
DK1897014T3 (en) 2014-03-10
US20070003965A1 (en) 2007-01-04
JP2008547030A (ja) 2008-12-25
RU2008102835A (ru) 2009-08-10
NO20080559L (no) 2008-01-30
CN100594501C (zh) 2010-03-17
AU2006265381B2 (en) 2010-06-10
NZ563431A (en) 2012-05-25
WO2007003343A1 (en) 2007-01-11
EP1897014B1 (en) 2014-01-15
CA2608963C (en) 2014-08-26
EP1897014A1 (en) 2008-03-12
NO339319B1 (no) 2016-11-28
WO2007003344A3 (en) 2007-04-26
US8265877B2 (en) 2012-09-11
AU2006265381A1 (en) 2007-01-11
US20070004044A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
IL187470A0 (en) Device for quantitative analysis of a metabolite profile
IL205271A0 (en) Immunoassay analysis method
GB0602127D0 (en) Gait analysis
GB0611981D0 (en) Spectroscopic analysis methods
EP1901056A4 (en) Analyzer
GB2422951B (en) Integrated analytical device
PL1866651T3 (pl) Sposób analizy próbek krwi
ZA200710087B (en) Method for identifying guignardia citricarpa
GB2464222B (en) Analysis method
EP1884766A4 (en) BIOCHEMICAL ANALYSIS PROCESS
GB201106398D0 (en) Parallel mass analysis
GB201200068D0 (en) Parallel mass analysis
GB2428871B (en) Device for spectroscopy using charged analytes
GB0509898D0 (en) Analysis method
LT1738157T (lt) Prietaisas skirtas analizuoti elementus
GB2438313B (en) Apparatus for analyzing a liquid sample using a multiple-lumen capillary
ZA200709815B (en) Device for quantitative analysis of a metabolite profile
GB0814683D0 (en) Apparatus for analysing a sample and assessing its global position
GB2441953B (en) Measuring a sample
GB0619126D0 (en) System for movement analysis
GB0506598D0 (en) Analysis device
EP1963827A4 (en) ANALYSIS DEVICE
GB0511461D0 (en) A method of analysis
GB0501725D0 (en) A method of analysis
EP1825251A4 (en) METHOD FOR THE ANALYSIS OF LIPOPROTEINS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed